Lee Tien-Li 4
4 · Aardvark Therapeutics, Inc. · Filed Oct 16, 2025
Insider Transaction Report
Form 4
Lee Tien-Li
DirectorChief Executive Officer10% Owner
Transactions
- Exercise/Conversion
Stock option (right to buy)
2025-10-15−1,229→ 40,566 totalExercise: $4.24Exp: 2034-07-20→ Common Stock (1,229 underlying) - Exercise/Conversion
Common Stock
2025-10-15$4.24/sh+1,229$5,211→ 1,544,613 total
Holdings
- 1,474,028(indirect: By Spouse)
Common Stock
Footnotes (1)
- [F1]1/48th of the original number of shares subject to the option vested on July 27, 2024, and 1/48th of the original number of shares subject to the option vested or shall vest in monthly installments thereafter, subject to the Reporting Person's continuous service through each vesting date, inclusive.